Secchi Massimiliano, Lodola Camilla, Garbelli Anna, Bione Silvia, Maga Giovanni
Institute of Molecular Genetics, IGM CNR "Luigi Luca Cavalli-Sforza", Via Abbiategrasso 207, 27100 Pavia, Italy.
Cancers (Basel). 2022 Aug 6;14(15):3820. doi: 10.3390/cancers14153820.
RNA helicases of the DEAD-box family are involved in several metabolic pathways, from transcription and translation to cell proliferation, innate immunity and stress response. Given their multiple roles, it is not surprising that their deregulation or mutation is linked to different pathological conditions, including cancer. However, while in some cases the loss of function of a given DEAD-box helicase promotes tumor transformation, indicating an oncosuppressive role, in other contexts the overexpression of the same enzyme favors cancer progression, thus acting as a typical oncogene. The roles of two well-characterized members of this family, DDX3X and DDX5, as both oncogenes and oncosuppressors have been documented in several cancer types. Understanding the interplay of the different cellular contexts, as defined by the molecular interaction networks of DDX3X and DDX5 in different tumors, with the cancer-specific roles played by these proteins could help to explain their apparently conflicting roles as cancer drivers or suppressors.
DEAD盒家族的RNA解旋酶参与多种代谢途径,从转录和翻译到细胞增殖、先天免疫和应激反应。鉴于它们的多种作用,它们的失调或突变与包括癌症在内的不同病理状况相关也就不足为奇了。然而,在某些情况下,特定DEAD盒解旋酶的功能丧失会促进肿瘤转化,表明其具有肿瘤抑制作用,而在其他情况下,同一酶的过表达则有利于癌症进展,因此起到典型癌基因的作用。该家族两个特征明确的成员DDX3X和DDX5作为癌基因和肿瘤抑制基因的作用已在多种癌症类型中得到证实。了解由不同肿瘤中DDX3X和DDX5的分子相互作用网络所定义的不同细胞环境之间的相互作用,以及这些蛋白质所发挥的癌症特异性作用,可能有助于解释它们作为癌症驱动因子或抑制因子时明显相互矛盾的作用。